S. Frank's Profile

Role	Title	Level	Year	L/R
🐬	Mechanisms of thymidine kinase/ganciclovir and cytosine deaminase/ 5-fluorocytosine suicide gene therapy-induced cell death in glioma cells U. Fischer, S. Steffens, S. Frank, N. Rainov, K. Schulze-Osthoff, C. Kramm	6	2005	6 🐬
🐜	Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linked 11 auth. M. Lilienfeld-Toal, S. Frank, C. Leyendecker, S. Feyler, Sarah J. Jarmin, Ruth S. M. Morgan, ... A. Glasmacher, A. Märten, I. Schmidt-Wolf, P. Brossart, G. Cook	5	2010	5 🐜
🐬	Cytokine-induced killer cells are type II natural killer T cells Stefan Gütgemann, S. Frank, J. Strehl, I. Schmidt-Wolf	5	2007	5 🐬
🐬	Suppressor cell function defect in idiopathic systemic lupus erythematosus. R. Krakauer, J. Clough, S. Frank, J. Sundeen	5	1979	5 🐬
🐜	Activated gammadelta T cells express the natural cytotoxicity receptor natural killer p 44 and show cytotoxic activity against myeloma cells. 7 auth. M. von Lilienfeld-Toal, J. Nattermann, G. Feldmann, E. Sievers, S. Frank, J. Strehl, ... I. Schmidt-Wolf	4	2006	4 🐜
🐜	Enhanced green fluorescent protein fusion proteins of herpes simplex virus type 1 thymidine kinase and cytochrome P450 4B1: Applications for prodrug-activating gene therapy 8 auth. S. Steffens, S. Frank, U. Fischer, C. Heuser, K. L. Meyer, K. Dobberstein, ... N. Rainov, C. Kramm	4	2000	4 🐜
🐬	Deficiency of T cell mediated regulation of anti-DNA production in systemic lupus erythematosus. J. Clough, S. Frank, L. Calabrese	4	1980	4 🐬
🐜	A recombinant anti-carcinoembryonic antigen immunoreceptor with combined CD3ζ-CD28 signalling targets T cells from colorectal cancer patients against their tumour cells 8 auth. A. Hombach, C. Schlimper, E. Sievers, S. Frank, H. Schild, T. Sauerbruch, ... I. Schmidt-Wolf, H. Abken	4	2005	4 🐜